Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?

Aims: This report describes three patients suffering from nodular regenerative hyperplasia (NRH).

[1]  P. Hsu,et al.  Nodular regenerative hyperplasia of the liver. , 2008, Journal of the Chinese Medical Association : JCMA.

[2]  T. Pawlik,et al.  Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  C. Tournigand,et al.  OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  L. Rubbia‐Brandt,et al.  Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. , 2006, Journal of the American College of Surgeons.

[5]  W. Hawkins,et al.  Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. , 2005, Journal of the American College of Surgeons.

[6]  T. de Baère,et al.  Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. , 2005, Radiology.

[7]  T. Hickish,et al.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.

[8]  L. Rubbia‐Brandt,et al.  Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  C. Tournigand,et al.  FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  K. Ishak,et al.  Histopathology of portal hypertension: a practical guideline , 2003, Histopathology.

[11]  Yu-ping Gong.  A Clinicopathologic Study of 24 Cases with Cystadenofibroma of the Ovary , 2003 .

[12]  G. McDonald,et al.  Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). , 2002, Seminars in liver disease.

[13]  G. Everson,et al.  Benign focal lesions of the liver. , 2001, Clinics in liver disease.

[14]  E. Abdalla,et al.  Portal vein embolization: rationale, technique and future prospects , 2001, The British journal of surgery.

[15]  C. Wilson,et al.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  K. Shimamatsu,et al.  Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver , 1997, Hepatology.

[17]  S. Thorgeirsson,et al.  Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells. , 1997, Journal of hepatology.

[18]  W. Meyers,et al.  Nodular Regenerative Hyperplasia in Partial Hepatectomy Specimens , 1993, American Journal of Surgical Pathology.

[19]  R. Knodell,et al.  Nodular regenerative hyperplasia: a cause of ascites and hepatomegaly after chemotherapy for leukemia. , 1991, The American journal of gastroenterology.

[20]  Y. Nakanuma.  Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. , 1990, Journal of clinical gastroenterology.

[21]  I. Wanless.  micronodular transpormation (nodular regenerative hyperplasia) of the liver: A report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules , 1990, Hepatology.

[22]  F. Colina,et al.  Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. , 2008, Liver.

[23]  J. Bloomer,et al.  Nodular regenerative hyperplasia of the liver following bone marrow transplantation , 1989, Hepatology.

[24]  K. Ishak,et al.  Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. , 1987, AJR. American journal of roentgenology.

[25]  E. HilarioRodríguez,et al.  Diffuse nodular regenerative hyperplasia of the liver associated with autoimmune hemolytic anemia. Presentation of a case and review of the literature , 1983 .

[26]  K. Ishak,et al.  Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. , 1981, Human pathology.

[27]  T. Godwin,et al.  Nodular Regenerative Hyperplasia of the Liver in Hematologic Disorders: A Possible Response to Obliterative Portal Venopathy , 1980 .

[28]  T. Godwin,et al.  Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. , 1980, Medicine.

[29]  U. Pastorino,et al.  Oxaliplatin Toxicity Masquerading As Recurrent Colon Cancer , 2022 .